# Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache

> **NCT00534560** · PHASE2 · COMPLETED · sponsor: **Minster Research Ltd** · enrollment: 542 (actual)

## Conditions studied

- Migraine Without Aura
- Migraine With Aura

## Interventions

- **DRUG:** Tonabersat
- **DRUG:** Tonabersat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00534560
- **Lead sponsor:** Minster Research Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-11
- **Final completion:** 2009-03
- **Target enrollment:** 542 (ACTUAL)
- **Last updated:** 2009-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00534560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00534560, "Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00534560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*